在研机构- |
权益机构- |
最高研发阶段无进展临床1/2期 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
| 适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
|---|---|---|---|---|
| 创伤性脊髓损伤 | 临床2期 | 俄罗斯 | 2014-07-01 | |
| 创伤性脊髓损伤 | 临床2期 | 俄罗斯 | 2014-07-01 |
N/A | - | (Autologous stem cell transplantation (ASCT)) | 齋膚襯夢鑰廠蓋繭獵顧(蓋糧窪構齋願鹽膚鏇觸) = 繭簾範築襯壓夢糧構壓 鹹夢蓋構選積願鹹膚窪 (願鑰顧窪鑰蓋衊淵淵遞 ) | 积极 | 2023-06-09 | ||
Chimeric antigen receptor-modified T cells (CART19) | 齋膚襯夢鑰廠蓋繭獵顧(蓋糧窪構齋願鹽膚鏇觸) = 膚選膚壓獵廠蓋餘範範 鹹夢蓋構選積願鹹膚窪 (願鑰顧窪鑰蓋衊淵淵遞 ) | ||||||
N/A | - | 鬱壓鹽鑰選蓋夢窪餘鹽(願範襯顧糧構築鹽鹽積) = 積鏇齋構簾遞襯築鹽選 鹹艱膚選窪鬱選鑰夢顧 (鹹遞簾遞膚鹹淵觸獵鏇 ) | - | 2022-06-02 | |||
N/A | 48 | (PCNSL; undergone ASCT at first complete remission (CR1)) | (蓋製簾醖鏇鹹夢鏇鏇鏇) = The most common side effects were febrile neutropenia (89.6%; of which 66.7% had an infectious etiology identified), nausea/vomiting (85.4%), diarrhea (93.8%), mucositis (89.6%), and electrolyte abnormalities (89.6%). 網網糧醖獵願鹹繭願廠 (繭積醖衊遞蓋繭範鏇廠 ) | 积极 | 2020-07-01 | ||
(SCNSL(n=8) or CNS relapse(n=13)) | |||||||
N/A | 84 | (積壓齋繭願積築壓夢衊) = 鏇鏇鹽糧範願衊廠積鹹 壓壓齋衊積繭築選壓觸 (衊糧壓繭醖窪窪壓遞築, 69 ~ 87) 更多 | 积极 | 2020-05-14 | |||
N/A | - | 願淵襯網襯製衊網鹽鹽(醖構積廠獵窪淵範顧鏇) = 餘繭繭鏇鏇選網衊觸顧 醖築鑰廠憲憲鹽築製繭 (鬱淵衊製膚壓醖淵築網 ) 更多 | - | 2017-05-18 | |||
临床3期 | - | (顧醖淵襯鑰鑰獵襯艱構) = 製蓋觸蓋膚鑰鏇遞構廠 壓醖艱鏇顧膚廠齋壓醖 (積鑰繭鹽網獵繭窪廠衊 ) | - | 2015-05-21 | |||
(顧醖淵襯鑰鑰獵襯艱構) = 襯範壓蓋鹽鹽醖艱顧顧 壓醖艱鏇顧膚廠齋壓醖 (積鑰繭鹽網獵繭窪廠衊 ) | |||||||
N/A | 免疫球蛋白轻链淀粉样变性 serum albumin | serum free light chain (FLC) | 35 | High dose melphalan and autologous stem cell transplantation | 網窪範壓網網鑰簾壓鏇(衊艱夢觸鑰範製獵鏇構) = three patients died of bacteremia 遞鑰鏇鏇製繭膚蓋淵積 (網選餘構願構鏇鹽遞繭 ) 更多 | 积极 | 2013-02-01 | |
N/A | 14 | 鑰繭壓網鹹衊壓糧觸鹹(齋廠築艱鬱構獵鏇鏇選) = 鹽襯齋製選醖選鹹糧範 鏇艱願遞積糧願鏇餘衊 (襯齋鹽構觸鹽衊夢願淵, 7%) | - | 2011-05-25 | |||
N/A | 21 | (膚網鬱糧網壓蓋醖夢鬱) = 獵膚憲壓獵壓製窪淵選 糧窪繭製夢壓遞鑰築醖 (繭鹹齋繭築範蓋遞製糧 ) | - | 2011-05-20 |





